Advanced search
Publication Cover
Infectious Diseases Volume 50, 2018 - Issue 10
Submit an article Journal homepage
894
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Predictors of one-year all-cause mortality and infection-related mortality in patients with Staphylococcus aureus bacteraemia

Arne Nørgaard EskesenDepartment of Infectious Diseases, Medical Division, Akershus University Hospital, Lørenskog, Norway; Correspondence[email protected]
,
Margrethe Astrup BelleDepartment of Infectious Diseases, Medical Division, Akershus University Hospital, Lørenskog, Norway;
&
Anita BlomfeldtDepartment of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway; ;Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital and University of Oslo, Lørenskog, Norway
Pages 743-748 | Received 03 Mar 2018, Accepted 24 Apr 2018, Published online: 10 May 2018

References

  • Mejer N, Westh H, Schønheyder HC, et al. Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC Infect Dis. 2012;12:260.
  • Laupland KB, Lytikäinen O, Søgard M, et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect. 2013;19:465–471.
  • Blomfeldt A, Eskesen AN, Aamodt HV, et al. Population-based epidemiology of Staphylococcus aureus blodstream infection: clonal complex 30 genotype is associated with mortality. Eur J Clin Microbiol Infect Dis. 2016;35:803–813.
  • Jacobsson G, Gustafsson E, Andersson R. Outcome for invasive Staphylococcus aureus infections. Eur J Clin Microbiol Infect Dis. 2008;27:839–848.
  • Turnidge JD, Kotsanas D, Munckhof W, et al. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust. 2009;191:368–373.
  • van Hal SJ, Jensen SO, Vaska VL, et al. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25:362–386.
  • Fätkenheuer G, Preuss M, Salzberger B, et al. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2004;23:157–162.
  • Hanses F, Spaeth C, Ehrenstein BP, et al. Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection. 2010;38:465–470.
  • Jacobsson G, Nasic S. Long-term outcome of invasive Staphylococcus aureus infections. Scand J Inf Dis. 2012;44:350–354.
  • Yahav D, Yassin S, Shaked H, et al. Risk factors for long-term mortality of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2016;35:785–790.
  • Gotland N, Uhre ML, Mejer N, et al. Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study. J Infect. 2016;73:346–357.
  • Huggan PJ, Wells JE, Browne M, et al. Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand. Intern Med J. 2010;40:117–125.
  • Asgeirsson H, Thalme A, Weiland O. Staphylococcus aureus bacteraemia and endocarditis – epidemiology and outcome: a review. Infect Dis (Lond). 2018;50:175–192.
  • Friedman ND, Kaye KS, Stout JE, et al. Healthcare-associated bloodstream infections in adult: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–797.
  • Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29:530–538.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
  • Lodise TP, McKinnon PS, Swiderski L, et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Inf Dis. 2003;36:1418–1423.
  • Paul M, Kariv G, Goldberg E, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2010;65:2658–2665.
  • Kim SH, Park WB, Lee CS, et al. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores. Clin Microbiol Infect. 2006;12:13–21.
  • Ammerlaan H, Seifert H, Harbarth S, et al. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis. 2009;49:997–1005.
  • Wenzel RP, Gennings C. Residual attributable mortality, a new concept for understanding the value of antibiotics in treating life-threatening acute infections. Antimicrob Agents Chemother. 2010;54:4956–4960.
  • Brady M, Oza A, Cunney R, et al. Attributable mortality of hospital-acquired bloodstream infections in Ireland. J Hosp Infect. 2017;96:35–41.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.